Panel Recommends Conditional Approval of TMJ Implants' Prosthetic Device
This article was originally published in The Gray Sheet
Executive Summary
TMJ Implants, Inc. should conduct a prospective, three to five-year study to gather long-term safety and efficacy data on a patient population classified according to interventional history and individual patient indication, FDA's Dental Products Panel concluded May 11 in Gaithersburg, Maryland.